Vistin Pharma ASA: Invitation to Q2 2022 conference call

Oslo, Norway, 11 August 2022

Vistin Pharma ASA will release its second quarter and YTD 2022 results on Friday 19^th of August 2022. Vistin Pharma will host a conference call for all shareholders and interested parties at the same day; Friday 19^th of August at 08:30 CET. There will be a Q&A session following the management discussion.

The conference call will be held in English.

The second quarter conference call will be available via webcast and audio through the following access points:

Webcast:
https://edge.media-server.com/mmc/p/m83myj4s

Telephone conference (online registration):
https://register.vevent.com/register/BI3e5ac1165d974dacab56dd8f81b4fba4

*****

For further information, please contact:

Alexander Karlsen
CFO
+47 97053621
alexander.karlsen@vistin.com

About Vistin Pharma | www.vistin.com

Vistin Pharma is a Norwegian pharmaceutical company producing Metformin Hydrochloride (API). The Metformin is also available as Direct Compressible lubricated granules. As a solely dedicated European Metformin producer, Vistin Pharma is a well–positioned supplier to leading pharmaceutical companies. Vistin Pharma is headquartered in Oslo, Norway, and has highly qualified employees and a dedicated manufacturing facility in Kragerø.